Skip to main content
Log in

Role of sialic acid in acquired dysfibrinogenemia associated with liver cirrhosis

  • Original Contributions
  • Published:
Ricerca in clinica e in laboratorio

Summary

The possible existence of acquired dysfibrinogenemia was investigated in blood samples from 30 patients with liver cirrhosis, 15 newborns and 30 healthy control subjects. Alterations of thrombin time were found in newborns and in 14 cirrhotic patients; glucide fraction levels were measured in these subjects and an increase in sialic acid content was observed. Its functional role was studied by comparing thrombin time and electrophoretic mobility of purified and desialylated forms of fibrinogen. We observed a thrombin time normalization, which was initially prolonged upon the removal of the sialic acid. The anodic electrophoretic mobility underwent changes due to the removal of sialic acid.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aminoff D.: Methods for the quantitative estimation ofN-acetylneuraminic acid and their application to hydrolysates of sialomucoids — Biochem. J.81, 384, 1961.

    PubMed  CAS  Google Scholar 

  2. Aznar J., Tascon A., Aznar J. A., Rodriguez-Inerba M.: Técnica rápida para la valoración del fibrinógeno por el método de precipitación por calor — Rev. Diagn. biol. (Madr.)22, 373, 1973.

    Google Scholar 

  3. Barr R. D., Allardyce M., Brunt P. W., McPhie J. L.: Dysfibrinogenemia and liver cell growth — J. clin. Pathol.31, 89, 1978.

    Article  PubMed  CAS  Google Scholar 

  4. Barr R. D., Ouna N., Simpson J. C., Bagshawe A. F.: Dysfibrinogenemia and primary hepatocellular carcinoma — Quart. J. Med.45, 647, 1976.

    PubMed  CAS  Google Scholar 

  5. Bloom A. L.: Intravascular coagulation and liver — Brit. J. Haematol.30, 1, 1975.

    Article  CAS  Google Scholar 

  6. Bohn H., Haupt H.: Eine quantitative Bestimmung von Faktor XIII mit Anti-Faktor-XIII-Serum — Thrombos. Diathes. haemorrh. (Stuttg.)19, 309, 1968.

    CAS  Google Scholar 

  7. Cessi C., Piliego F.: The determination of amino sugars in the presence of amino acids and glucose — Biochem. J.77, 508, 1960.

    PubMed  CAS  Google Scholar 

  8. Clauss A.: Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens — Acta haematol. (Basel)17, 237, 1957.

    Article  CAS  Google Scholar 

  9. Grabar P., Williams C. A.: Méthode immunoélectrophorétique d’analyse de mélanges de substances antigèniques — Biochim. biophys. Acta (Amst.)17, 67, 1955.

    Article  CAS  Google Scholar 

  10. Gralnick H., Givelber H., Abrams E.: Dysfibrinogenemia associated with hepatoma: increased carbohydrate content of fibrinogen molecule — New Engl. J. Med.299, 221, 1978.

    PubMed  CAS  Google Scholar 

  11. Jim R. T. S.: A study of the plasma thrombin — J. Lab. clin. Med.50, 45, 1957.

    PubMed  CAS  Google Scholar 

  12. Kwan S. W., Fuller G. H.: Immunochemical characterization of fibrinogen induction in rat liver — Biochim. biophys. Acta (Amst.)475, 659, 1977.

    CAS  Google Scholar 

  13. Lane D. A., Scully M. F., Thomas D. P., Kakkar V. V., Woolf I. L., Williams R.: Acquired dysfibrinogenaemia in acute and chronic liver disease — Brit. J. Haematol.35, 301, 1977.

    Article  CAS  Google Scholar 

  14. Laurell C.-B.: Electroimmunoassay — Scand. J. clin. Lab. Invest.29 (Suppl. 21), 124, 1972.

    Google Scholar 

  15. Martinez J., Palascak J., Kwasniak D.: Abnormal sialic acid content of the dysfibrinogenemia associated with liver disease — J. clin. Invest.61, 535, 1978.

    Article  PubMed  CAS  Google Scholar 

  16. Merskey C., Lalezari P., Johnson A. J.: A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum — Proc. Soc. exp. Biol. (N.Y.)131, 871, 1969.

    CAS  Google Scholar 

  17. Mester L., Szabados L.: Structure défectueuse et biosynthèse des fractions glucidiques dans les variantes pathologiques du fibrinogène — Nouv. Rev. franç. Hématol.10, 679, 1970.

    CAS  Google Scholar 

  18. Narvaiza M. J.: Contribución al estudio de las alteraciones funcionales y físicoquímicas del fibrinógeno en la cirrosis hepática. Tesis doctoral, Universidad de Navarra, 1979.

  19. Palascak J., Martinez J.: Dysfibrinogenemia associated with liver disease — J. clin. Invest.60, 89, 1977.

    Article  PubMed  CAS  Google Scholar 

  20. Ratnoff O. D., Menzie C.: A new method for the determination of fibrinogen in small samples of plasma — J. Lab. clin. Med.37, 316, 1951.

    PubMed  CAS  Google Scholar 

  21. Roberts H. R., Cederbaum A. I.: The liver and blood coagulation: physiology and pathology — Gastroenterology63, 297, 1972.

    PubMed  CAS  Google Scholar 

  22. Soria J., Soria C., Durand G., Feger J.: Electrofocalisation de fibrinogènes anormaux en gel de polyacrylamide — Ann. Biol. clin.30, 161, 1972.

    CAS  Google Scholar 

  23. Straub P. W., Funk C.: The Reptilase time in presence of fibrinogen degradation products — Scand. J. Haematol.13 (Suppl.), 257, 1971.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Narvaiza, M.J., Fernández, J., Cuesta, B. et al. Role of sialic acid in acquired dysfibrinogenemia associated with liver cirrhosis. La Ricerca Clin. Lab. 16, 563–568 (1986). https://doi.org/10.1007/BF02886840

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02886840

Key-words

Navigation